Rejuvenated A Year Into Saunders’ Return To Helm, B+L Refreshing Blink, Lumify Lines
Brimonidine tartrate eye drops remain key sales driver among Canadian firm’s consumer health lines with 12% growth in the latest quarter. B+L expects pending launch of preservative-free line extension to sustain Lumify as a driver as generics of original formulation are approved.
